{"altmetric_id":742634,"counts":{"readers":{"mendeley":47,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["oncology_nurse_advisor"],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":1,"unique_users":["nixon786"],"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:26968071"],"posts_count":1}},"selected_quotes":["@chasingthealpha GPNMB is an inde fac for breast ca recur. I think that is whyit was targeted. this is a nice"],"citation":{"abstract":"Although the murine orthologue of glycoprotein nonmetastatic B (GPNMB), Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance in human breast cancer is unknown. We have examined the significance of GPNMB expression as a prognostic indicator of recurrence and assessed its potential as a novel therapeutic target in breast cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Rose AA","Grosset AA","Dong Z","Russo C","Macdonald PA","Bertos NR","St-Pierre Y","Simantov R","Hallett M","Park M","Gaboury L","Siegel PM"],"doi":"10.1158\/1078-0432.ccr-09-1611","first_seen_on":"2012-05-14T16:49:57+00:00","issns":["1557-3265","1078-0432"],"issue":"7","journal":"Clinical Cancer Research","last_mentioned_on":1462195027,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/16\/7\/2147.long","http:\/\/dx.doi.org\/10.1158\/1078-0432.CCR-09-1611","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20215530"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/16\/7\/2147.full.pdf","pmid":"20215530","pubdate":"2010-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"title":"Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.","type":"article","volume":"16","mendeley_url":"http:\/\/www.mendeley.com\/research\/glycoprotein-nonmetastatic-b-independent-prognostic-indicator-recurrence-novel-therapeutic-target-br-1"},"altmetric_score":{"score":12.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.5},"context_for_score":{"all":{"total_number_of_other_articles":7639268,"mean":6.5692022176954,"rank":586171,"this_scored_higher_than_pct":92,"this_scored_higher_than":7048662,"rank_type":"exact","sample_size":7639268,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":93932,"mean":5.1261556887503,"rank":6837,"this_scored_higher_than_pct":92,"this_scored_higher_than":86991,"rank_type":"exact","sample_size":93932,"percentile":92},"this_journal":{"total_number_of_other_articles":5153,"mean":5.6297864906832,"rank":349,"this_scored_higher_than_pct":93,"this_scored_higher_than":4801,"rank_type":"exact","sample_size":5153,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":44,"mean":2.2832558139535,"rank":2,"this_scored_higher_than_pct":95,"this_scored_higher_than":42,"rank_type":"exact","sample_size":44,"percentile":95}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":14,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":10,"Student  > Postgraduate":5,"Student  > Master":6,"Other":6,"Student  > Bachelor":2,"Professor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":12,"Physics and Astronomy":1,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":21,"Biochemistry, Genetics and Molecular Biology":4,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":3,"Veterinary Science and Veterinary Medicine":1}}},"geo":{"mendeley":{"JP":2,"MY":1,"FR":1,"AU":1}}},"posts":{"wikipedia":[{"title":"Glembatumumab vedotin","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=395526102#altmetric_citation_2","license":"public","citation_ids":[742634],"posted_on":"2010-11-08T11:23:51+00:00","summary":"Glembatumumab vedotin (also known as CDX-011 and CR011-vcMMAE) is an antibody-drug conjugate (ADC) that targets cancer cells expressing transmembrane glycoprotein NMB (GPNMB).","page_url":"http:\/\/en.wikipedia.org\/?curid=26968071","wiki_lang":"en","author":{"name":"Rod57","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rod57"}}],"twitter":[{"url":"http:\/\/twitter.com\/#!\/nixon786\/status\/202077892627271680","citation_ids":[742634],"posted_on":"2012-05-14T16:48:18+00:00","author":{"name":"nixon786","image":"https:\/\/pbs.twimg.com\/profile_images\/1726581351\/002_arabskie_loshadki_normal.jpg","description":"Physician investing in Biotech. Not an investment advise or recommendation to buy & sell. Please do your own DD.","id_on_source":"nixon786","tweeter_id":"314061974","geo":{"lt":null,"ln":null},"followers":1289},"tweet_id":"202077892627271680"}],"news":[{"title":"A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer","url":"http:\/\/www.oncologynurseadvisor.com\/a-review-of-systemic-treatment-in-metastatic-triple-negative-breast-cancer\/article\/493356\/","license":"public","citation_ids":[4966295,3923455,3923455,7121791,7121792,617074,617074,724678,724678,7121794,7121795,7121796,1988471,512200,7121800,7121802,7121803,1359370,3096223,7121808,210512,210512,7121812,512238,7121814,4122538,4122538,7121816,1193609,2983403,517781,3092076,3092076,7121819,7121820,7121821,7121822,7121823,7121824,7121825,7121826,868948,868948,7121828,7121829,7121830,7121832,7121834,7121836,7121837,7121841,7121842,7121843,7121844,7121846,7121847,7121848,7121849,7121850,2949152,7121851,2492718,3447625,7121855,654504,147615,7121860,193458,193458,791850,791850,432298,2607210,1871996,410500,104178,4531397,4531397,2728335,7121871,7121871,2338277,2338277,7121873,2115433,2115433,1309542,1309542,7121874,2861399,2861399,4469166,4469166,1025306,1025306,6057241,6057241,6091163,6091163,1798171,742634,7121891,2707642,2707642,7121896,3935288,2589414,2589414,1241731,2712027,750270,7121906,7121908,3914960,186456,186456,5425815,5425815,6085338,6085338],"posted_on":"2016-05-02T13:17:07+00:00","summary":"May 02, 2016 the ONA take: Approximately 246 660 patients are expected to receive a diagnosis of breast cancer in the United States in 2016.","author":{"name":"Oncology Nurse Advisor ","url":"http:\/\/www.oncologynurseadvisor.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/276\/normal\/Screen_Shot_2014-11-20_at_11.19.42.png?1416482413"}}]}}